Rapid generation of mouse model for emerging infectious disease with the case of severe COVID-19
暂无分享,去创建一个
Yun-Ju Lai | J. Jan | Y. Ko | S. Hsieh | I-Hsuan Wang | Yi-Ling Lin | M. Tao | Ping-Yi Wu | Wen-Chun Liu | Jian-Jong Liang | Yen-Hui Chen | Chun-Che Liao | Hsiu-Hua Ma | Cheng-Pu Sun | T. Ko | Zong-Lin Sie | Yi-Ching Tsai | Hui-Ying Ko | Ming-Tsai Chiang | Han-Chung Wu | Jing-Rong Wang | Liang-Yu Chen | Joyce Pei-Yi Yuan | I-Jung Lee | Yu-Hua Lan | Szu-I Tsung | Yin-Shiou Lin | Hsin-Ni Liao | Tzu-Jiun Kuo | Chia-Wei Li | Cheng‐Pu Sun
[1] R. Baric,et al. Developing therapeutic approaches for twenty-first-century emerging infectious viral diseases , 2021, Nature Medicine.
[2] J. Zehnder,et al. Strand-Specific Reverse Transcription PCR for Detection of Replicating SARS-CoV-2 , 2021, Emerging infectious diseases.
[3] Zhaohui Zheng,et al. CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells , 2020, Signal Transduction and Targeted Therapy.
[4] S. Perlman,et al. COVID-19 Treatments and Pathogenesis Including Anosmia in K18-hACE2 mice , 2020, Nature.
[5] M. Mohan,et al. Animal Models for SARS-CoV-2 research: A Comprehensive Literature Review. , 2020, Transboundary and emerging diseases.
[6] Shengdian Wang,et al. Neutrophil‐to‐lymphocyte ratio, a critical predictor for assessment of disease severity in patients with COVID‐19 , 2020, International journal of laboratory hematology.
[7] Malik Peiris,et al. Virology, transmission, and pathogenesis of SARS-CoV-2 , 2020, BMJ.
[8] P. Pickkers,et al. Cytokine Levels in Critically Ill Patients With COVID-19 and Other Conditions. , 2020, JAMA.
[9] G. Martens,et al. Transduction patterns in the CNS following various routes of AAV-5-mediated gene delivery , 2020, Gene Therapy.
[10] Shamus P. Keeler,et al. SARS-CoV-2 infection of hACE2 transgenic mice causes severe lung inflammation and impaired function , 2020, Nature Immunology.
[11] Robert J. Fischer,et al. K18-hACE2 mice develop respiratory disease resembling severe COVID-19 , 2020, bioRxiv.
[12] A. Iwasaki,et al. Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling , 2020, The Journal of experimental medicine.
[13] C. Hallam,et al. Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice , 2020, Nature Communications.
[14] Sharon J Peacock,et al. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. , 2020, JAMA.
[15] Man Kong,et al. Higher level of neutrophil-to-lymphocyte is associated with severe COVID-19 , 2020, Epidemiology and Infection.
[16] A. García-Sastre,et al. Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 Infection , 2020, bioRxiv.
[17] Francesco Castelli,et al. Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics , 2020, The Lancet Infectious Diseases.
[18] Chengliang Zhu,et al. Immune Phenotyping Based on the Neutrophil-to-Lymphocyte Ratio and IgG Level Predicts Disease Severity and Outcome for Patients With COVID-19 , 2020, Frontiers in Molecular Biosciences.
[19] H. Krumholz,et al. Extrapulmonary manifestations of COVID-19 , 2020, Nature Medicine.
[20] S. Farhadian,et al. Neuroinvasion of SARS-CoV-2 in human and mouse brain , 2020, bioRxiv.
[21] P. Matthews,et al. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study , 2020, The Lancet Psychiatry.
[22] Tokiko Watanabe,et al. Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development , 2020, Proceedings of the National Academy of Sciences.
[23] P. Pelosi,et al. Multiple organ dysfunction in SARS-CoV-2: MODS-CoV-2 , 2020, Expert review of respiratory medicine.
[24] Larissa B. Thackray,et al. A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies , 2020, Cell.
[25] Rongchang Chen,et al. Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment , 2020, Cell.
[26] J. Mikes,et al. Systems-Level Immunomonitoring from Acute to Recovery Phase of Severe COVID-19 , 2020, Cell Reports Medicine.
[27] T. Zhao,et al. A Mouse Model of SARS-CoV-2 Infection and Pathogenesis , 2020, Cell Host & Microbe.
[28] Zachary Schiffman,et al. Predicting infectious SARS-CoV-2 from diagnostic samples , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[29] P. Zhou,et al. Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2 , 2020, Cell.
[30] Victor G. Puelles,et al. Multiorgan and Renal Tropism of SARS-CoV-2 , 2020, The New England journal of medicine.
[31] M. Merad,et al. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages , 2020, Nature Reviews Immunology.
[32] R. Schwartz,et al. Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19 , 2020, Cell.
[33] M. Tay,et al. The trinity of COVID-19: immunity, inflammation and intervention , 2020, Nature Reviews Immunology.
[34] T. Kuiken,et al. Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model , 2020, Science.
[35] Nan Tang,et al. SARS-CoV-2 and viral sepsis: observations and hypotheses , 2020, The Lancet.
[36] M. Netea,et al. Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure , 2020, Cell Host & Microbe.
[37] Yan Zhao,et al. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19 , 2020, Journal of Infection.
[38] Eun-Ha Kim,et al. Infection and Rapid Transmission of SARS-CoV-2 in Ferrets , 2020, Cell Host & Microbe.
[39] P. Vollmar,et al. Virological assessment of hospitalized patients with COVID-2019 , 2020, Nature.
[40] Linqi Zhang,et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor , 2020, Nature.
[41] S. Ciesek,et al. SARS‐CoV‐2 asymptomatic and symptomatic patients and risk for transfusion transmission , 2020, medRxiv.
[42] K. To,et al. Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[43] Christl A. Donnelly,et al. Estimates of the severity of coronavirus disease 2019: a model-based analysis , 2020, The Lancet Infectious Diseases.
[44] Jie Hao,et al. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection , 2020, Frontiers of Medicine.
[45] G. Herrler,et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.
[46] Wenling Wang,et al. Age‐related rhesus macaque models of COVID‐19 , 2020, Animal models and experimental medicine.
[47] J. Xiang,et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.
[48] K. Yuen,et al. Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.
[49] H. Rothan,et al. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak , 2020, Journal of Autoimmunity.
[50] Andrea Marzi,et al. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses , 2020, Nature Microbiology.
[51] Young-Jun Park,et al. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein , 2020, Cell.
[52] B. Graham,et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation , 2020, Science.
[53] Xingyi Ge,et al. The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future , 2020, Microbes and Infection.
[54] Lijuan Xiong,et al. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients , 2020, EBioMedicine.
[55] Wenling Wang,et al. The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice , 2020, Nature.
[56] R. Samulski,et al. Engineering adeno-associated virus vectors for gene therapy , 2020, Nature Reviews Genetics.
[57] Kai Zhao,et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin , 2020, Nature.
[58] Ralph S. Baric,et al. Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus , 2020, Journal of Virology.
[59] G. Gao,et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019 , 2020, The New England journal of medicine.
[60] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[61] J. Nie,et al. Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2 , 2020, Emerging microbes & infections.
[62] William A Liguore,et al. AAV-PHP.B Administration Results in a Differential Pattern of CNS Biodistribution in Non-human Primates Compared with Mice. , 2019, Molecular therapy : the journal of the American Society of Gene Therapy.
[63] Chuan Qin,et al. Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection. , 2019, JCI insight.
[64] S. Wootton,et al. AAV vector distribution in the mouse respiratory tract following four different methods of administration , 2017, BMC Biotechnology.
[65] Y. Saga,et al. Optimization of adeno-associated virus vector-mediated gene transfer to the respiratory tract , 2017, Gene Therapy.
[66] L. Zentilin,et al. A mouse model for adult cardiac-specific gene deletion with CRISPR/Cas9 , 2015, Proceedings of the National Academy of Sciences.
[67] R. Desrosiers,et al. Global CNS transduction of adult mice by intravenously delivered rAAVrh.8 and rAAVrh.10 and nonhuman primates by rAAVrh.10. , 2014, Molecular therapy : the journal of the American Society of Gene Therapy.
[68] R. Baric,et al. Rapid generation of a mouse model for Middle East respiratory syndrome , 2014, Proceedings of the National Academy of Sciences.
[69] Christian Drosten,et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC , 2013, Nature.
[70] I. Alexander,et al. Comparison of gene transfer to the murine liver following intraperitoneal and intraportal delivery of hepatotropic AAV pseudo-serotypes , 2012, Gene Therapy.
[71] C. Mueller,et al. Several rAAV vectors efficiently cross the blood-brain barrier and transduce neurons and astrocytes in the neonatal mouse central nervous system. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.
[72] D. Dickson,et al. Nuclear translocation of AMPK-α1 potentiates striatal neurodegeneration in Huntington’s disease , 2011, The Journal of cell biology.
[73] Xiao Xiao,et al. Comparative study of anti-hepatitis B virus RNA interference by double-stranded adeno-associated virus serotypes 7, 8, and 9. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.
[74] H. Sweeney,et al. Adeno-associated virus (AAV) serotype 9 provides global cardiac gene transfer superior to AAV1, AAV6, AAV7, and AAV8 in the mouse and rat. , 2008, Human gene therapy.
[75] J. Rabinowitz,et al. Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.
[76] L. Fritts,et al. Interferon-Induced Expression of MxA in the Respiratory Tract of Rhesus Macaques Is Suppressed by Influenza Virus Replication1 , 2008, The Journal of Immunology.
[77] C. Halbert,et al. High-efficiency promoter-dependent transduction by adeno-associated virus type 6 vectors in mouse lung. , 2007, Human gene therapy.
[78] Michelle M. Packard,et al. Severe Acute Respiratory Syndrome Coronavirus Infection of Mice Transgenic for the Human Angiotensin-Converting Enzyme 2 Virus Receptor , 2006, Journal of Virology.
[79] David K. Meyerholz,et al. Lethal Infection of K18-hACE2 Mice Infected with Severe Acute Respiratory Syndrome Coronavirus , 2006, Journal of Virology.
[80] James M. Allen,et al. Adeno-Associated Virus Type 6 (AAV6) Vectors Mediate Efficient Transduction of Airway Epithelial Cells in Mouse Lungs Compared to That of AAV2 Vectors , 2001, Journal of Virology.
[81] R. Samulski,et al. Production of High-Titer Recombinant Adeno-Associated Virus Vectors in the Absence of Helper Adenovirus , 1998, Journal of Virology.
[82] J. Luban. SARS-CoV-2 , 2020 .
[83] T. Flotte,et al. Recombinant AAV serotype and capsid mutant comparison for pulmonary gene transfer of alpha-1-antitrypsin using invasive and noninvasive delivery. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.
[84] T. Flotte,et al. Recombinant AAV Serotype and Capsid Mutant Comparison for Pulmonary Gene Transfer of α-1-Antitrypsin Using Invasive and Noninvasive Delivery. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.
[85] M. Tao,et al. Long-term inhibition of hepatitis B virus in transgenic mice by double-stranded adeno-associated virus 8-delivered short hairpin RNA , 2007, Gene Therapy.